Form 4: Elanco Animal Health Executive Rajeev A. Modi Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units representing the right to receive common stock or cash equivalent.

Summary

  • On May 16, 2025, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc, acquired deferred stock units.
  • These deferred stock units represent the right to receive one share of Elanco's common stock or the cash equivalent.
  • A total of 109.4907 deferred stock units were acquired at a price of $12.92, resulting in 6,154.0076 directly owned.
  • The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to executive compensation. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and insider transactions, which is common in publicly traded companies like Elanco Animal Health. It provides transparency into the holdings and transactions of company executives.

Key Dates

DateDescription
05/16/2025Date of transaction: Rajeev A. Modi acquired deferred stock units.
05/20/2025Date of signature on the Form 4 filing.

Keywords

Elanco Animal Health, Rajeev A. Modi, Deferred Stock Units, Form 4, Executive Compensation, Beneficial Ownership, Securities Exchange Act, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.